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Twin-twin transfusion syndrome:
neurodevelopmental screening test
Síndrome de transfusão feto-fetal: teste de triagem do desenvolvimento neurológico
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ABSTRACT
Objective: To assess the neurodevelopmental functions (cognition, language and motor function) of survivors of twin-twin transfusion
syndrome (TTTS). Method: Observational cross-sectional study of a total of 67 monochorionic diamniotic twins who underwent fetoscopic
laser coagulation (FLC) for treatment of TTTS. The study was conducted at the Center for Investigation in Pediatrics (CIPED), Universidade
Estadual de Campinas. Ages ranged from one month and four days to two years four months. Bayley Scales of Infant and Toddler
Development Screening Test-III, were used for evaluation. Results: Most children reached the competent category and were classified as
having appropriate performance. The preterm children scored worse than term infants for gross motor subtest (p = 0.036). Conclusion: The
majority of children reached the expected development according to their age. Despite the good neurodevelopment, children classified at
risk should be monitored for development throughout childhood.
Keywords: child, child development, diseases in twins, fetofetal transfusion.
RESUMO
Objetivo: Avaliar as funções do desenvolvimento neurológico (cognição, linguagem e motricidade) de sobreviventes da síndrome de
transfusão feto-fetal (STFF). Método: Estudo transversal observacional, total de 67 gêmeos diamnióticos monocoriônicos submetidos à
coagulação a laser por fetoscopia para o tratamento da STFF. O estudo foi realizado no Centro de Investigação em Pediatria (CIPED),
Universidade Estadual de Campinas. A idade variou entre um mês e quatro dias a dois anos e quatro meses. Foram utilizadas as Bayley
Scales of Infant and Toddler Development Screening Test-III para avaliação. Resultados: A maioria das crianças atingiu a categoria
competente e foi classificada como tendo desempenho adequado. As crianças prematuras obtiveram desempenho inferior quando
comparadas às nascidas a termo no subteste motor global (p = 0,036). Conclusão: A maioria das crianças alcançou o desenvolvimento
esperado de acordo para idade. Apesar do bom desenvolvimento neurológico, crianças classificadas na categoria de risco devem ser
monitoradas para o desenvolvimento, durante a infância.
Palavras-chave: criança, desenvolvimento infantil, doenças em gêmeos, transfusão feto-fetal.
Twin-twin transfusion syndrome (TTTS) occurs in
approximately 10%-15% of all monochorionic diamniotic
twin pregnancies, develops typically between 15 and 26
weeks of gestation and is associated with a high perinatal
morbidity and mortality1,2,3.
The pathophysiology of TTTS is an unbalanced trans-
fusion of blood across placental vascular anastomoses from
one twin (donor) to the other (recipient). Twin-twin trans-
fusion syndrome results in a volume-depleted donor twin
with signs of oliguria and oligo/anhydramnios and a volume-
overloaded recipient twin with polyuria and polyhydramnios,
which may lead to impairment of various organ systems in
both affected twins4.
Serial amnioreduction and fetoscopic laser coagulation
(FLC) of placental anastomoses are the two main treatment
options in chronic TTTS. According to a Cochrane systematic
review, FLC results in higher survival rates and better neonatal
outcomes than amnioreduction, and more babies were alive
without neurological abnormality at the age of six months in
the laser group than in the amnioreduction group (52% vs. 31%)5.
Nonetheless, the incidence of severe neurological morbid-
ity remains high in survivors of TTTS treated by FLC, ranging
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from an estimated 6% to 18% of cases. Cerebral injury in
TTTS treated with laser surgery is not fully prevented.
Periventricular hemorrhagic infarction, and ischemic white
matter damage have been detected antenatally in fetuses
treated with laser therapy for TTTS6. The incidence of cerebral
damage may be underestimated because neurodevelopmen-
tal impairments and intellectual disability may manifest sev-
eral months or years after birth6.
The risk factors for the TTTS group are early gestational
age (GA) at delivery, advanced Quintero stage, late GA at
operation, the higher incidence of prematurity and low birth
weight4,6,7. Multiple risk factors increase the risk of devel-
opmental disability, by either additive or multiplicative
effects. All children should have their development moni-
tored during infancy and childhood because of a baseline
incidence of neurodevelopmental disability.
Clearly, the TTTS group requires careful screening and
assessment for neurological development. Due to uncer-
tainty about the long-term neurological and cognitive devel-
opment after laser treatment for TTTS, some authors
suggest that children should be examined at two years,
and that the next appropriate time point is the beginning
of school age around six years3. With higher survival rates,
an increasing number of follow-up studies in TTTS survivors
are being published, shedding more light on long-term neu-
rodevelopmental outcome2.
Due to this uncertainty about the neurological devel-
opment of children after laser treatment, the primary aim
of this study was to assess survivors of TTTS with neurode-
velopmental scales that evaluate cognition, language and
motor functioning.
METHOD
The research design consisted of an observational cross-
sectional study that included monochorionic diamniotic
twins who underwent FLC for treatment of TTTS. The total
number of pregnancies that were treated was 41 (82 twin
children) and we investigated 67 surviving children (81.70%).
The mortality rate was 15 (18.30%), which occurred in the
fetal and neonatal period. All families invited agreed to par-
ticipate and signed the consent form. After data collection,
there was no waiver by any family.
This project was approved by the Research Ethics
Committee of the Medical School of the State University of
Campinas (UNICAMP) (process no. 899/2011).
Children were selected using the following inclusion cri-
teria: (i) children from monochorionic diamniotic twin preg-
nancies who had TTTS (stages I, II, III and IV according to
the classification of Quintero et al. 1999)8 and underwent
FLC; (ii) parents agreed to sign the informed consent; and
(iii) children who were between one month and 42 months
of age. An exclusion criterium was the presence of any other
malformation unrelated to TTTS.
All FLC procedures were performed by the same surgeon
(CFAP, who has seven years of experience in fetoscopic laser
surgeries) at the Professor José Aristodemo Pinotti Hospital,
from 2009 to 2012, according to the following technique: the
placenta’s chorionic plate vessels of the recipient fetus were
initially mapped endoscopically through the amniotic cavity;
the vascular equator (where most of the arterio-venous ana-
stomoses are expected to be) was identified; a line of abla-
tion of the chorionic plate was performed from one edge
of the placenta to the other, including the arterio-venous
anastomoses and vessels with unknown courses. Caution
was taken to preserve the vessels originating from and
returning to the same fetus, which were surrounded by this
line of ablation. At the end of the photocoagulation process,
polyhydramnios was drained through the fetoscopy sheath
so that the deepest amniotic fluid pocket was less than
8 cm deep.
Development was assessed using the Bayley Scales of
Infant and Toddler Development Screening Test, third edi-
tion9, which included 33 items for testing cognition, 24 items
for receptive communication, 24 items for expressive com-
munication, 27 items for fine motor skills and 26 items for
gross motor skills. These items can be administered in chil-
dren aged one to 42 months.
Each subtest (cognition, receptive language, expressive
language, gross motor and fine motor skills) has a starting
point consistent with the age or adjusted to the child’s
age. Every child is given an item score of zero or one. A zero
score (0) refers to a child who did not carry out the item or
failed to meet the criteria established by test. The score of
one (1) refers to a child who met criteria established by test,
showing adequate performance on the item.
To start the test, the child is required to achieve a score of
one (1) on the first item of his/her starting point previously
determined by chronological age or adjusted. The reversal
rule is applied when the child is given zero (0) in the first
item, requiring the examiner to revert to the previous start-
ing point. The test is completed when the child receives four
consecutive zeros.
At the end of the assessment a raw score is obtained for
each subtest, which classifies children into three categories:
competent (low risk for delay), emerging (requires sub-
sequent reviews) and risk (should be referred for diagnostic
assessment). To perform statistical analyses, the three cat-
egories of the Bayley Scale were grouped into two types of
responses: appropriate responses (consisting of the compet-
ent category), and inadequate responses (comprising emer-
ging and risk categories). Any suspicious behavior would
place the child in the inadequate response group; therefore,
the appropriate response group comprised children with
reliable development what strengthened our data.
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Neurological examination was performed by a pediatric
neurologist following our standard protocol10.
A normal neurological pattern was recorded when the
child had normal execution of the tests, and amended when
any evidence of abnormality was detected.
The infants were assessed at the CIPED of Universidade
Estadual de Campinas from July, 2011 to July, 2013. The
testing room was quiet, well lit, well ventilated, without
bright or colorful pictures and free of distraction9. All infants
were assessed in the presence of their mothers during inter-
vals between feeds, when infants were alert and cooperative.
The infants were evaluated only once.
Examinations were performed by an examiner and simul-
taneously monitored by one observer. The testers included
a developmental neurologist and three physiotherapists,
all members of the Interdisciplinary Group for Infant
Development Evaluation (GIADI).
Infants who presented with developmental changes were
referred for diagnostic confirmation, and then, if necessary,
referred to a program for habilitation.
Statistical analyses were performed using the Statistical
Package for Social Sciences for Personal Computer
(SPSS/PC 16.0). The a level adopted for rejection of the null
hypothesis was less than 0.05. The data were presented
using frequencies for categorical variables. The comparison
between cognitive, communication, motor performance
and neurological evaluation, in each assessment (starting
point), was investigated with the Fisher’s Exact Test and
Chi-Square Test. We used a significance level of p , 0.05.
RESULTS
We present an observational cross-sectional study of 67
twins who were survivors of TTTS after prenatal treatment
by FLC. The age range of the children in the study was
one month and four days to two years four months, taking
into consideration the adjusted age.
In our study, 10 of the 67 children (14.92%) had at least
one classification at risk for any of the Bayley Scale subtests
(cognitive, receptive communication, expressive commun-
ication, fine motor, gross motor). On the Bayley Scales, the
risk classification indicates that the child should be referred
for diagnostic assessment.
The descriptive analysis of sample characteristics of the
TTTS and birth is presented in Table 1. Most of the children
were female (61.2%), were recipients (56.9%), were severe by
Quintero classification (stages II, III and IV) (89.6%), were
appropriate for gestational age (68.7%), were preterm
(89.6%), and had Apgar scores at 1 minute $ 7 (73.1%)
and 5 minutes $ 7 (69.6%).
The mean birth weight was 1.697g [0.470-3.300] and the
mean gestational age was 32.5 weeks [26.4-37.6]. Following
the Quintero classification, we found stage I consisted of
seven children (10.45%), stage II of 16 (23.88%), stage III of
28 (41.79%) and stage IV of 16 (23.88%).
The outcomes of classification according to the Bayley
scale subtests are listed in Table 2. For all subtests assessed
(cognitive, receptive and expressive communication, fine and
gross motor) the majority of children reached the competent
category, followed by those in the emerging category and the
minority of all children remained in the at-risk category.
Until this point, normal neurological development had been
observed in most of the children.
The classification according to appropriate or inadequate
performances is listed in Table 3. The trend in the classifica-
tion of normality is observed again, as most of the children
were classified as appropriate for development.
In Table 4, all subscales of the Bayley and neurological
examination were statistically evaluated for the variables
Table 1. Clinical characteristics of all Twin-twin transfusion syndrome (TTTS) cases before FLC (N = 67).
Gender F M Total
41 (61.2) 26 (38.8) 67 (100.0)
Donor/Recipients D R
28 (43.1) 37 (56.9) 65* (100.0)
Quintero Stage II, III, IV I
60 (89.6) 7 (10.4) 67 (100.0)
Fetal Growth SGA AGA
21 (31.3) 46 (68.7) 67 (100.0)
Gestational Age Preterm Term
60 (89.6) 7 (10.4) 67 (100.0)
Apgar Score - 1st , 7 $ 7
7 (10.4) 49 (73.1) 56** (100.0)
Apgar Score - 5th , 7 $ 7
2 (3.4) 56 (69.6) 58*** (100.0)
FLC: Fetoscopic laser coagulation; F: Female; M: Male; D: Donor; R: Recipients; Quintero Stage (II-IV: severe; I: mild); Fetal Growth (SGA: small for
gestational age; AGA: adequate for gestacional age); Apgar Score - 1st minute; Apgar Score - 5th minute; * Missing 2 cases; ** Missing 11 cases; *** Missing
9 cases.
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gender ( female/male), donor/recipient, ranking in Quintero
stages, classification of fetal growth (appropriate for GA
and small for GA), classification of GA at birth (preterm/
term) and the Apgar score for the 1st and 5th minutes. Our
data showed no significant differences differences with
respect to the variables evaluated: cognition, receptive com-
munication, expressive communication, fine and gross
motor function and neurological examination.
Our results demonstrated a single statistically significant
difference (p = 0.036) in the gross motor subtest. We found a
significantly higher rate of term children with adequate per-
formance (100.0%) when compared to preterm infants who
scored adequately (55%).
Most of our children were premature. The minimum GA
was 26 weeks and four days, the average was 32 weeks and
five days, and maximum was 37 weeks and six days. Three
children (4.47%) were extremely premature infants (GA less
than 28 weeks); 37 children (55.22%) were moderately pre-
term infants (28-33 weeks of GA); and, 20 children
(29.85%) were late preterm infants. Only seven children
(10.45%) were born at term.
Sixty-three patients (94.03%) underwent neurological
examination, which revealed nine children with strabismus
(14.28%), two children with microcephaly (3.17%), one child
with obstetric brachial plexus injury (1.58%), and four chil-
dren with spastic cerebral palsy (5.97%), three of them with
tetraparesis and one with hemiparesis. Neurological evalu-
ation could not be performed in four patients (5.97%).
These children could not be examined due to tiredness.
DISCUSSION
The focus of this study was to assess survivors of
TTTS with neurodevelopmental scales that evaluate cog-
nition, language and motor functioning. Most children
presented with adequate development for assessed age.
They were classified in the competent category and
reached appropriate performance in the five subtests of
the Bayley Scales.
This study represents one of the few Brazilian studies
addressing the neurological development of monochorionic
diamniotic twins who underwent FLC for treatment of TTTS.
The assessment tool utilized in this study is one of the most
used in similar studies and has an overall acceptance; more-
over, it was managed by an experienced team. All FLC proce-
dures were performed by the same surgeon. We believe that
the reasons above irrevocably strengthen our findings.
Our study has five limitations: (1) the sample was small,
mainly because it is a rare syndrome, which made collecting
data extremely laborious; (2) the age group distribution of
the children evaluated in this research is extensive covering
one month to 42 months of life. This fact must be especially
because we are dealing with a rare syndrome that leads to
preterm birth and its complications; (3) we performed a
transversal assessment; (4) we may have missed some chil-
dren with cerebral palsy, because it is very difficult to dia-
gnose cerebral palsy in very young children; and (5) we
used a non-standard assessment tool for the Brazilian popu-
lation. There is a scarcity of assessment tools validated and
standardized in Brazil. However, the Bayley Scales have an
overall acceptance.
Our data suggest that FLC treatment was an effective
procedure to allow normal development in most infants.
Compared with other treatment options like serial amnio-
centeses, the FLC seems to achieve both higher survival
rates and a lower rate of long-term morbidity, such as neu-
rologic or developmental abnormality. Besides, it is well
established that the amnioreduction is associated with an
increased risk of severe cerebral injury compared to laser
surgery in survivors of TTTS4,11,12. Therefore, laser treatment
seems to be the treatment of choice, since the incidence
of cerebral palsy in the group of survivors treated with
Table 2. Classification according to the Bayley scale subtests (N = 67).
Subtests
Categories
Competent
f (%)
Emerging
f (%)
Risk
f (%)
Cognitive 50 (74.6) 13 (19.4) 4 (6.0)
Receptive Communication 55 (82.1) 10 (14.9) 2 (3.0)
Expressive Communication 40 (59.7) 24 (35.8) 3 (4.5)
Fine Motor 45 (67.2) 18 (26.9) 4 (6.0)
Gross Motor 40 (59.7) 23 (34.3) 4 (6.0)
f: Frequency; %: Percentage.
Table 3. Classification according to appropriate or inad-
equate performances (N = 67).
Subtests
Performances
Appropriate
f (%)
Inadequate
f (%)
Cognitive 50 (74.6) 17 (25.4)
Receptive Communication 55 (82.1) 12 (17.9)
Expressive Communication 40 (59.7) 27 (40.3)
Fine Motor 45 (67.2) 22 (32.8)
Gross Motor 40 (59.7) 27 (40.3)
f: Frequency; %: Percentage.
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amnioreduction series reached 26%7,6,13,14,15,16,17. However,
special care should be taken when different studies are com-
pared because discrepant results may partly be due to differ-
ent methodology, selection criteria, and definitions of
neurodevelopmental impairment12.
Our data showed that 14.92% of our children had at least
one classification at risk for any of the Bayley Scale subtests.
Our results are in keeping with other studies that found
neurological impairment (minor or severe) ranging from
4.6% to 17% after FLC procedure6,7,11,12,13,16,17. Another inter-
esting finding was that neurodevelopmental impairment
occurred in 10% of monochorionic diamniotic twin pregnan-
cies without TTTS18. This finding overlaps with our data sug-
gesting that the FLC procedure only slightly increases the
risk of a neurological complication and these infants need
careful neurodevelopmental monitoring.
Our children were mostly female, recipients, classified in
stages II, III and IV of the Quintero classification, were
appropriate for GA, were preterm, and obtained Apgar
scores of $ 7 at the first minute and $ 7 at five minutes.
Risk factors for neurodevelopmental disability in survivors
of TTTS treated with FLC are: low GA at birth; severity of
disease assessed by Quintero classification (stages II, III
and IV); low birthweight; and intrauterine growth restriction.
It seems that low GA at birth is the major risk factor for
adverse neurodevelopmental outcome. There is no increased
risk between donors and recipients, either when the two sib-
lings survived or when only one child survived1,2,3,11,12,19,20,21,22.
Although our data showed significant prematurity (89.6%)
and advanced stages of Quintero (89.6% in stage II, III, IV)
as major points of concern, our children reached the
expected responses and were classified mostly within the
normal range of development.
When our children were compared for gender,
donor/recipient, Quintero stages, classification of fetal growth,
and Apgar score, we found no significant difference either for
Bayley Scale subtests or for the neurological examination.
However, when the children were divided into two groups
according to GA, the preterm group showed lower perform-
ance on the gross motor subtest (55% achieved the expected
responses) than the term group (100% achieved the expected
responses). We also found four children in our cohort who
could be diagnosed as having cerebral palsy.
It is quite clear that prematurity may correlate with
motor development delay and unfavourable outcome23,24,25,26.
In keeping with our findings, another study27 utilized Alberta
Infant Motor Scale and found gross motor deficits. This find-
ing reinforces our data, since another developmental scale
also demonstrated similar abnormality in preterm infants.
One of the important factors possibly influencing the
motor development in preterm infants is the brain maturation
process. It has been shown that premature birth has an influ-
ence on structural maturation manifested as a decrease in
cortical and deep gray matter volume, smaller cerebral
surface area, smaller cerebral volume, decreasedmyelinization,
decreased gray and white matter differentiation, volume
reduction in the cerebellum, corpus callosum, hippocampus,
basal ganglia, thalami, and larger volume of the ventricles28,29,30.
In conclusion, despite the relatively good neurodevelop-
mental outcome in the present study, it is recommended
that children classified in the category of emerging, and
especially those classified at risk, should be monitored for
development throughout childhood. By adopting this pro-
cedure, diagnosis and early intervention could occur if
necessary. A better prognosis in childhood undoubtedly
influences the quality of life in adolescence and adulthood.
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